← back to search

Zegao Zhou

Hebei Medical University · CN
Area of research
Surgery · Molecular Biology
Research interest
Research interests include Cholangiocarcinoma and Gallbladder Cancer Studies, Circular RNAs in diseases, Healthcare and Venom Research, and Cancer-related molecular mechanisms research.
h-index
5
citations
108
works
10
NIH funding
primary concept
email

Recent publications

Bee venom promotes exosome secretion and alters miRNA cargo in T cells
Open Life Sciences 2025cited by 0position: middledoi
Melittin and phospholipase A2: Promising anti-cancer candidates from bee venom
Biomedicine & Pharmacotherapy 2024cited by 31position: middledoi
Identification of potential prognostic biomarkers among gene models for coiled-coil domain-containing family members in hepatocellular carcinoma elucidates their influence on the hypoxia pathway and immune microenvironment
Journal of Gastrointestinal Oncology 2023cited by 6position: middledoi
Bee venom protects against pancreatic cancer via inducing cell cycle arrest and apoptosis with suppression of cell migration
Journal of Gastrointestinal Oncology 2022cited by 22position: middledoi
Explore the value of ERCP in patients with choledocholithiasis after Billroth II gastrointestinal anastomosis
International Journal of Surgery 2019cited by 0position: middledoi
Diagnosis and treatment of small intestinal angioma comorbid with mesenteric hemangioma
Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi 2019cited by 0position: middledoi
Expression of microRNA-218 in cholangiocarcinoma and its effect on the apoptosis of cholangiocarcinoma cells
Zhonghua shiyan waike zazhi 2018cited by 0position: middledoi
Study on the correlation of the effect of microRNA-218 through Survivin on cholangiocarcinoma cells
Zhonghua shiyan waike zazhi 2018cited by 0position: middledoi
MiR-7 inhibits progression of hepatocarcinoma by targeting KLF-4 and promises a novel diagnostic biomarker
Cancer Cell International 2017cited by 28position: middledoi
Stress Hormone Cortisol Enhances Bcl2 Like-12 Expression to Inhibit p53 in Hepatocellular Carcinoma Cells
Digestive Diseases and Sciences 2017cited by 20position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Sanguang Liu · Hebei Medical University4 papers (2017–2018)Yunfei Liang · China University of Mining and Technology4 papers (2017–2018)Wei‐Zhong Wu · Fudan University4 papers (2017–2018)Changqing Yan · Shandong University of Science and Technology3 papers (2019–2025)Xueqing Liu · Heilongjiang University of Chinese Medicine3 papers (2017–2018)Jiayue Duan · Hebei Medical University3 papers (2019–2024)Changqing Yan · Peking University2 papers (2022–2024)Ziyan Cui · Hebei Medical University2 papers (2024–2025)Runtian Liu · Hebei Medical University2 papers (2024–2025)Zhaolong Wang · Shanghai Jiao Tong University2 papers (2018–2018)Ziyan Sun · Yangzhou University2 papers (2024–2025)Jing Li · Fudan University1 papers (2023–2023)Jianhua Liu · Guangdong Medical College1 papers (2019–2019)Hao Liu · Tianjin Agricultural University1 papers (2022–2022)Hao Liu · Zhejiang Chinese Medical University1 papers (2023–2023)Feng Feng · Shandong Provincial Hospital1 papers (2019–2019)Zheng Dong · Harbin Medical University1 papers (2022–2022)Wenbin Wang · Anhui Medical University1 papers (2019–2019)Xueqing Liu · Stevens Institute of Technology1 papers (2017–2017)Weiguo Hu · Shanghai Medical College of Fudan University1 papers (2022–2022)